These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18175259)

  • 1. American Society of Nephrology--40th Annual Conference (renal week 2007).
    Wu-Wong JR
    IDrugs; 2008 Jan; 11(1):30-2. PubMed ID: 18175259
    [No Abstract]   [Full Text] [Related]  

  • 2. Update in nephrology. Highlights from the 36th Annual Meeting of the American Society of Nephrology.
    Cases A
    Drugs Today (Barc); 2004 Jan; 40(1):81-92. PubMed ID: 14988772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The latest findings in basic and clinical nephrology science.
    Cases A
    Drug News Perspect; 2005 Apr; 18(3):205-14. PubMed ID: 15915223
    [No Abstract]   [Full Text] [Related]  

  • 4. The latest advances in kidney diseases and related disorders.
    Cases A
    Drug News Perspect; 2007 Dec; 20(10):647-54. PubMed ID: 18301799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal endpoints in renal and cardiovascular randomized clinical trials: time for a consensus?
    Halimi JM; Sautenet B; Gatault P; Roland M; Giraudeau B
    Fundam Clin Pharmacol; 2012 Dec; 26(6):771-82. PubMed ID: 21851387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guidelines of the Spanish Society of Nephrology: the kidney and cardiovascular disease. Short version].
    Marín R; Goicoechea MA; Gorostidi M; Cases A; Díez J; Escolar G; Fernández-Vega F; Palomar R; Rodrigo E; Martínez I; Segura J;
    Nefrologia; 2006; 26(1):31-44. PubMed ID: 16649424
    [No Abstract]   [Full Text] [Related]  

  • 7. Controversies in chronic kidney disease, anaemia and cardiovascular disease.
    Fluck R
    Br J Hosp Med (Lond); 2008 Oct; 69(10):580-6. PubMed ID: 18949948
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances in nephrology.
    Cases A
    Drug News Perspect; 2003 Sep; 16(7):471-7. PubMed ID: 14668943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension and cardiovascular risk in chronic kidney disease patients.
    Luño J; Rodriguez-Iturbe B; Ayus JC
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S157-8. PubMed ID: 17130254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prerenal uremia in chronic renal diseases. I. Prerenal uremia due to circulatory failure.
    Orlowski Z
    Pol Med J; 1969; 8(4):839-45. PubMed ID: 5404477
    [No Abstract]   [Full Text] [Related]  

  • 11. American Heart Association--Scientific Sessions 2008--Studies with investigative drugs--Part 2.
    Kirkham K
    IDrugs; 2009 Jan; 12(1):7-9. PubMed ID: 19127495
    [No Abstract]   [Full Text] [Related]  

  • 12. American Heart Association--Scientific Sessions 2008--Studies with investigative drugs--Part 1.
    Kirkham K
    IDrugs; 2009 Jan; 12(1):5-6. PubMed ID: 19127494
    [No Abstract]   [Full Text] [Related]  

  • 13. Endothelin receptor antagonists and cardiovascular disease.
    Jarvis B; Duff R; Elkinson S
    Drugs R D; 1999 Jul; 2(1):13-6. PubMed ID: 10610274
    [No Abstract]   [Full Text] [Related]  

  • 14. Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease.
    Vaziri ND; Zhou XJ
    Nephrol Dial Transplant; 2009 Apr; 24(4):1082-8. PubMed ID: 18987263
    [No Abstract]   [Full Text] [Related]  

  • 15. Outpatient management of chronic kidney disease: proteinuria, anemia and bone disease as therapeutic targets.
    Lam A; Shah S; Paparello J
    Am J Ther; 2008; 15(3):278-86. PubMed ID: 18496265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transition of patients from chronic kidney disease to end-stage renal disease: better practices for better outcomes.
    Amedia CA; Perazella MA
    Dis Manag; 2006 Dec; 9(6):311-5. PubMed ID: 17115878
    [No Abstract]   [Full Text] [Related]  

  • 17. Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue.
    Toussaint ND; Elder GJ; Kerr PG
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):221-33. PubMed ID: 18987295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Growth factors in the treatment of bone deficiencies and bone diseases].
    Heikinheimo K; Kokkari A; Turunen T; Aro H
    Duodecim; 2004; 120(3):311-8. PubMed ID: 15061009
    [No Abstract]   [Full Text] [Related]  

  • 19. European Society of Cardiology--2009 annual congress. 31 August - 2 September 2009, Barcelona, Spain.
    Wong NC
    IDrugs; 2009 Nov; 12(11):675-8. PubMed ID: 19844849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of surrogate endpoints in regulating medicines for cardio-renal disease: opinions of stakeholders.
    Schievink B; Lambers Heerspink H; Leufkens H; De Zeeuw D; Hoekman J
    PLoS One; 2014; 9(9):e108722. PubMed ID: 25268242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.